Glycogen storage disease type II MRI: Difference between revisions
No edit summary |
No edit summary |
||
Line 13: | Line 13: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Metabolic disorders]] | |||
[[Category:Radiology]] | |||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}} |
Latest revision as of 19:42, 23 January 2018
Glycogen storage disease type II Microchapters |
Differentiating Glycogen storage disease type II from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type II MRI On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type II MRI |
Directions to Hospitals Treating Glycogen storage disease type II |
Risk calculators and risk factors for Glycogen storage disease type II MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
There are no MRI findings associated with glycogen storage disease type 2 (GSD type 2). However, an MRI may be helpful in the diagnosis of neurologic complications of GSD type 2, which include central and cortical atrophy.
MRI
- There are no MRI findings associated with glycogen storage disease type 2 (GSD type 2). However, an MRI may be helpful in the diagnosis of neurologic complications of GSD type 2, which include:[1]
- Central and cortical atrophy
References
- ↑ van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT; et al. (2003). "The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature". Pediatrics. 112 (2): 332–40. PMID 12897283.